Encapsulated cannabinoid formulations for transdermal delivery

A method for treating a subject, comprising:

• topically administering a cannabinoid composition into the subject in a dose amount effective to treat the subject's symptoms;
• wherein the cannabinoid composition comprises:
• an oil phase composition comprising:
• a cannabinoid preparation;
• at least one non-ionic surfactant, wherein the non-ionic surfactant comprises a hydrophilic compartment and a hydrophobic compartment;
• and
• at least one co-solvent;
• a water phase composition comprising
• water;
• and
• a stabilizing agent;
• wherein the oil phase composition and the water phase composition are mixed to form micelles within a microemulsion having uni-, bi-, or multi-lamellar structures;
• wherein said cannabinoid composition yields the cannabinoid preparation capable of having increased bioavailability when topically administered;
• and wherein the at least one non-ionic surfactant forms a self-assembling emulsion in a self-emulsifying drug delivery system.